487 related articles for article (PubMed ID: 15190525)
1. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
[TBL] [Abstract][Full Text] [Related]
2. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
3. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
De la Cruz-Mosso U; García-Iglesias T; Bucala R; Estrada-García I; González-López L; Cerpa-Cruz S; Parra-Rojas I; Gámez-Nava JI; Pérez-Guerrero EE; Muñoz-Valle JF
Cell Immunol; 2018 Feb; 324():42-49. PubMed ID: 29397904
[TBL] [Abstract][Full Text] [Related]
4. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus.
Postal M; Peliçari KO; Sinicato NA; Marini R; Costallat LT; Appenzeller S
Cytokine; 2013 Mar; 61(3):785-91. PubMed ID: 23332615
[TBL] [Abstract][Full Text] [Related]
5. Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles.
Guimarães PM; Scavuzzi BM; Stadtlober NP; Franchi Santos LFDR; Lozovoy MAB; Iriyoda TMV; Costa NT; Reiche EMV; Maes M; Dichi I; Simão ANC
Immunol Cell Biol; 2017 Oct; 95(9):824-831. PubMed ID: 28649995
[TBL] [Abstract][Full Text] [Related]
6. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.
Arora V; Verma J; Marwah V; Kumar A; Anand D; Das N
Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832
[TBL] [Abstract][Full Text] [Related]
7. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
8. The relationship between Th1/Th2-type cells and disease activity in patients with systemic lupus erythematosus.
Chen S; Hu D; Shi X; Shen N; Gu Y; Bao C
Chin Med J (Engl); 2000 Oct; 113(10):877-80. PubMed ID: 11775831
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.
Sabry A; Sheashaa H; El-Husseini A; Mahmoud K; Eldahshan KF; George SK; Abdel-Khalek E; El-Shafey EM; Abo-Zenah H
Cytokine; 2006 Aug; 35(3-4):148-53. PubMed ID: 17027280
[TBL] [Abstract][Full Text] [Related]
10. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.
Amerio P; Frezzolini A; Abeni D; Teofoli P; Girardelli CR; De Pità O; Puddu P
Clin Exp Rheumatol; 2002; 20(4):535-8. PubMed ID: 12175109
[TBL] [Abstract][Full Text] [Related]
11. Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
Raymond WD; Eilertsen GØ; Nossent J
Cytokine; 2019 Feb; 114():67-73. PubMed ID: 30551949
[TBL] [Abstract][Full Text] [Related]
12. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients.
McCarthy EM; Smith S; Lee RZ; Cunnane G; Doran MF; Donnelly S; Howard D; O'Connell P; Kearns G; Ní Gabhann J; Jefferies CA
Rheumatology (Oxford); 2014 Sep; 53(9):1586-94. PubMed ID: 24706988
[TBL] [Abstract][Full Text] [Related]
13. Hypertension is associated with serologically active disease in patients with systemic lupus erythematosus: role of increased Th1/Th2 ratio and oxidative stress.
Lozovoy MA; Simão AN; Morimoto HK; Iryioda TM; Panis C; Reiche EM; Borelli SD; Oliveira SR; Cecchini R; Dichi I
Scand J Rheumatol; 2014; 43(1):59-62. PubMed ID: 24134304
[TBL] [Abstract][Full Text] [Related]
14. Changes in the Ratio of T Helper 1 to T Helper 2 Signature Cytokines in Patients Undergoing Living Donor Liver Transplantation Surgery: A Prospective Controlled Study.
Lee HM; Ghill BK; Park E; Park CY; Choi WK; Lee J
Transplant Proc; 2018 Dec; 50(10):3621-3625. PubMed ID: 30577247
[TBL] [Abstract][Full Text] [Related]
15. Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus.
Iaccarino L; Ghirardello A; Zen M; Villalta D; Tincani A; Punzi L; Doria A
Reumatismo; 2012 Dec; 64(5):314-20. PubMed ID: 23256107
[TBL] [Abstract][Full Text] [Related]
16. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
17. The relation of interleukin 17 (IL-17) and IL-23 to Th1/Th2 cytokines and disease activity in systemic lupus erythematosus.
Mok MY; Wu HJ; Lo Y; Lau CS
J Rheumatol; 2010 Oct; 37(10):2046-52. PubMed ID: 20682672
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus.
Rana A; Minz RW; Aggarwal R; Anand S; Pasricha N; Singh S
Lupus; 2012 Sep; 21(10):1105-12. PubMed ID: 22759859
[TBL] [Abstract][Full Text] [Related]
19. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
[TBL] [Abstract][Full Text] [Related]
20. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
